NCT06150924: Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
- State
- Completed
- Phase
- Phase 2
- People
- 60 taking part
- Started
- 14 Dec 2023
- Primary completion
- 27 Feb 2025
- Arms
- Cohort 1
- Results
- Posted on the registry
- 29 Nov 2023: Trial registered
- 14 Dec 2023: Trial started
- 23 Apr 2025: Trial completed
- 3 Jun 2026: Trial results posted